Bradley Foster & Sargent Inc Eli Lilly & CO Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 20,623 shares of LLY stock, worth $16.1 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

20,623

Previous 20,181 2.19%

Holding current value

$16.1 Million

Previous $18.3 Million 0.01%

% of portfolio

0.31%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $341,285 - $424,328	442 Added 2.19%	20,623 $18.3 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $404,477 - $507,244	558 Added 2.84%	20,181 $18.3 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $428,160 - $572,818	723 Added 3.83%	19,623 $15.3 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.27 Million - $1.5 Million	-2,418 Reduced 11.34%	18,900 $11 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $130,826 - $174,929	373 Added 1.78%	21,318 $10 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $17,084 - $20,065	-55 Reduced 0.26%	20,945 $7.19 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $50,161 - $58,448	156 Added 0.75%	21,000 $7.68 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $4,150 - $4,730	14 Added 0.07%	20,844 $6.74 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $129,051 - $151,526	463 Added 2.27%	20,830 $6.75 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $892,056 - $1.11 Million	3,801 Added 22.94%	20,367 $5.83 Million
Q4 2021 Mar 11, 2022	BUY	$224.85 - $279.04 $140,531 - $174,400	625 Added 3.92%	16,566 $4.58 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $963,516 - $1.19 Million	-4,348 Reduced 21.43%	15,941 $3.68 Million
Q2 2021 Aug 19, 2021	SELL	$180.55 - $233.54 $81,247 - $105,093	-450 Reduced 2.17%	20,289 $4.66 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $1.99 Million - $2.57 Million	-12,100 Reduced 36.85%	20,739 $3.88 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $6,523 - $8,631	-50 Reduced 0.15%	32,839 $5.55 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $100,891 - $116,699	-690 Reduced 2.05%	32,889 $4.87 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $87,382 - $108,154	734 Added 2.23%	33,579 $4.66 Million
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $11,868 - $14,699	111 Added 0.34%	32,845 $4.32 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $17,620 - $19,166	-165 Reduced 0.5%	32,734 $3.66 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $25,592 - $29,872	-231 Reduced 0.7%	32,899 $3.65 Million
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $19,145 - $22,535	172 Added 0.52%	33,130 $4.3 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $378,063 - $423,544	-3,570 Reduced 9.77%	32,958 $3.81 Million
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $7,570 - $8,688	-100 Reduced 0.27%	36,528 $3.12 Million
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $83,337 - $98,374	1,123 Added 3.16%	36,628 $2.83 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $4,342 - $4,658	-53 Reduced 0.15%	35,505 $3 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $2.74 Million - $3.04 Million	35,558	35,558 $3.04 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Eli Lilly & CO Transaction History